Ameriprise Financial Inc Immutep LTD Transaction History

Ameriprise Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.84 - $3.9 $20,847 - $44,187	-11,330 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.45 - $3.7 $27,758 - $41,921	11,330 New	11,330 $42,000
Q1 2018 May 15, 2018	SELL	$1.64 - $2.13 $32,800 - $42,600	-20,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$1.32 - $2.72 $26,400 - $54,400	20,000	20,000 $31,000

2.41M

526K

222K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $172M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.